AstraZeneca PLC is 62.9x more valuable than AMICUS THERAPEUTICS, INC. by market capitalization ($286.27 B vs $4.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FOLD | AZN |
|---|---|---|
| Market cap | $4.55 B | $286.27 B |
| US-listed rank | #1468 | #45 |
| Revenue (latest FY) | $634.21M | - |
| Net income (latest FY) | -$27.11M | - |
| Net margin | -4.3% | - |
| SEC filings | 2,171 | 1,004 |
AstraZeneca PLC is 62.9x more valuable than AMICUS THERAPEUTICS, INC. by market capitalization ($286.27 B vs $4.55 B).
Full pages: AMICUS THERAPEUTICS, INC. and AstraZeneca PLC, or browse the full rankings.